In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species.

Autor: Tan MC; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan., Huang YC; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan., Chen PJ; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan., Huang WC; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan., Hsu SY; Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan., Wang HY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan., Liou CH; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan., Sun JR; Department of Pathology, Division of Clinical Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Lauderdale TY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan., Kuo SC; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan.
Jazyk: angličtina
Zdroj: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jan 03; Vol. 79 (1), pp. 200-202.
DOI: 10.1093/jac/dkad322
Databáze: MEDLINE